Psychiatry and Neurology, Neurology · Hamilton, NY
NPI
1710968730
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
164 Broad St
Hamilton, NY, 13346
Phone (315) 824-4600
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
628 services
Medicare patients, 2024
145
Average age 70
Drug cost, 2024
$2.1M
664 prescriptions
Company payments, 2025
$1,485
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eufrosina Young was code G0453 (continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)), 252 times for 46 patients. In total Eufrosina Young billed 628 services in 19 codes, and Medicare paid $32K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-11-19.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0453 Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 252 | 46 | $23.85 | $6,009 |
| 95938 Electrical Nerve Conductivity | Facility | 69 | 67 | $33.05 | $2,280 |
| 99215 Office E&M - Established | Facility | 52 | 30 | $94.19 | $4,898 |
| 95939 Electrical Nerve Conductivity | Facility | 45 | 44 | $84.84 | $3,818 |
| 99215 Office E&M - Established | Office | 42 | 25 | $101.11 | $4,247 |
| 95864 Electrical Nerve Conductivity | Facility | 38 | 37 | $78.85 | $2,996 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 17 | 12 | $12.54 | $213 |
| 99223 Hospital E&M - Initial | Facility | 14 | 14 | $130.85 | $1,832 |
| 95813 Neurologic | Facility | 14 | 14 | $55.27 | $774 |
| 95861 Electrical Nerve Conductivity | Facility | 12 | 12 | $61.04 | $732 |
| 99232 Hospital E&M - Subsequent | Facility | 11 | 11 | $59.57 | $655 |
By year: 2022 $30K for 595 services; 2023 $30K for 597 services; 2024 $32K for 628 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eufrosina Young prescribed most often to Medicare patients was Radicava Ors (Edaravone), with 129 prescriptions and refills. In total Eufrosina Young wrote 664 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Radicava Ors Edaravone | 129 | 129 | 18 | $1.7M |
| Riluzole Generic | 87 | 151 | 23 | $7,316 |
| Baclofen Generic | 66 | 107 | 18 | $1,632 |
| Nuedexta Dextromethorphan Hbr/Quinidine | 61 | 67 | 11 | $96K |
| Atropine Sulfate Generic | 30 | 39 | 17 | $1,943 |
| Scopolamine Generic | 28 | 32 | Under 11 | $3,675 |
| Gabapentin Generic | 27 | 31 | Under 11 | $347 |
| Lacosamide Generic | 18 | 18 | Under 11 | $1,479 |
| Levetiracetam Generic | 17 | 17 | Under 11 | $462 |
| Lamotrigine Generic | 16 | 32 | Under 11 | $299 |
| Mexiletine Hcl Generic | 16 | 24 | Under 11 | $1,423 |
| Mirtazapine Generic | 15 | 19 | Under 11 | $183 |
| Relyvrio Sod Phenylbutyrat/Taurursodiol | 15 | 15 | Under 11 | $186K |
| Diclofenac Sodium Generic | 14 | 14 | Under 11 | $182 |
| Glycopyrrolate Generic | 13 | 28 | Under 11 | $9,290 |
Brand drugs: - claims; generic drugs: 444 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eufrosina Young $1,485 ($1,485 in general payments such as food, travel and fees) from 2 companies. The largest payer was Tanabe Pharma America, Inc. with $1,228.
| Company | Payments | Amount |
|---|---|---|
| Tanabe Pharma America, Inc. | 3 | $1,228 |
| Biogen, Inc. BIIB | 2 | $257 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.